Basic demographic characteristics and smoking pattern of the success and failure group
| Variable | Total (n=202) | Success (n=148) | Failure (n=54) | P-value |
|---|---|---|---|---|
| Sex | 0.431 | |||
| Male | 188 (93.1) | 139 (93.9) | 49 (90.7) | |
| Female | 14 (6.9) | 9 (6.1) | 5 (9.3) | |
| Age | 52.7±11.7 | 53.5±12.2 | 52.4±11.5 | 0.580 |
| Alcohol consumption | 0.256 | |||
| Non-drinker | 45 (22.3) | 30 (20.3) | 15 (27.8) | |
| Drinker | 157 (77.7) | 118 (79.7) | 39 (72.2) | |
| Previous attempts of smoking cessation | 0.507 | |||
| No | 87 (43.5) | 66 (44.9) | 21 (39.6) | |
| Yes | 113 (56.5) | 81 (55.1) | 32 (60.4) | |
| Body mass index (kg/m2) | 0.287 | |||
| <23 | 48 (24.0) | 37 (25.3) | 11 (20.4) | |
| 23–24.99 | 41 (20.5) | 26 (17.8) | 15 (27.8) | |
| ≥25 | 111 (55.5) | 83 (56.8) | 28 (51.9) | |
| Marital status | 0.558 | |||
| Divorced, widowed or single | 31 (15.4) | 24 (16.3) | 7 (13.0) | |
| Married | 170 (84.6) | 123 (83.7) | 47 (87.0) | |
| Degree of education | 0.965 | |||
| High school | 62 (30.7) | 45 (30.4) | 17 (31.5) | |
| College | 104 (51.5) | 76 (51.4) | 28 (51.9) | |
| Graduate school | 36 (17.8) | 27 (18.2) | 9 (16.7) | |
| Type of comorbidities | 0.648 | |||
| HTN | 55 (27.2) | 43 (29.1) | 12 (22.2) | |
| DM | 8 (4.0) | 6 (4.1) | 2 (3.7) | |
| HTN+DM | 15 (7.4) | 12 (8.1) | 3 (5.6) | |
| Others | 124 (61.4) | 87 (58.8) | 37 (68.5) | |
| FTND score | 0.402 | |||
| ≤3 | 58 (29.6) | 39 (27.3) | 19 (35.8) | |
| 4–6 | 92 (46.9) | 71 (49.7) | 21 (39.6) | |
| ≥7 | 46 (23.5) | 33 (23.1) | 13 (24.5) | |
| Total years of smoking (y) | 0.781 | |||
| <20 | 31 (15.5) | 25 (17.0) | 6 (11.3) | |
| 20–29 | 46 (23.0) | 33 (22.4) | 13 (24.5) | |
| 30–39 | 73 (36.5) | 52 (35.4) | 21 (39.6) | |
| ≥40 | 50 (25.0) | 37 (25.2) | 13 (24.5) | |
| Age of smoking initiation (y) | 0.212 | |||
| <19 | 46 (23.0) | 35 (23.8) | 11 (20.8) | |
| 19–24 | 114 (57.0) | 87 (76.3) | 27 (50.9) | |
| ≥25 | 40 (20.0) | 25 (17.0) | 15 (28.3) | |
| Previous treatment | 0.210 | |||
| No medication | 104 (53.6) | 78 (55.3) | 26 (49.1) | |
| Pharmacological treatment other than Varenicline | 75 (38.7) | 55 (39.0) | 20 (37.7) | |
| Varenicline | 15 (7.7) | 8 (5.7) | 7 (13.2) | |
| Average number of days between sessions | 0.001 | |||
| <30 | 144 (71.3) | 115 (77.7) | 29 (53.7) | |
| ≥30 | 58 (28.7) | 33 (22.3) | 25 (46.3) | |
| Number of smoking cessation sessions | 0.913 | |||
| 3 | 59 (29.2) | 42 (28.4) | 17 (31.5) | |
| 4 | 71 (35.1) | 52 (35.1) | 19 (35.2) | |
| 5 | 36 (17.8) | 28 (18.9) | 8 (14.8) | |
| ≥6 | 36 (17.8) | 26 (17.6) | 10 (18.5) | |
| Pharmacological treatment | 0.272 | |||
| Varenicline only | 178 (88.1) | 133 (89.9) | 45 (83.3) | |
| Varenicline+NRT | 10 (5.0) | 7 (4.7) | 3 (5.6) | |
| NRT only | 13 (6.4) | 8 (5.4) | 5 (9.3) | |
| Others | 1 (0.5) | 0 (0.0) | 1 (1.9) |
Values are presented as number (%) or mean±standard deviation.
FTND, Fagerström test for nicotine dependence; HTN, hypertension; DM, diabetes mellitus; NRT, nicotine replacement therapy, including nicotine patch and nicotine gum.